Skip to main content

Your search for “SARS-CoV-2” returned 181 results

Leading Experts Call for Immediate Action to Address Inhalation Exposure to Prevent COVID-19

February 17, 2021

Leading scientific and medical experts, including researchers from the University of California San Diego, are calling upon the Biden Administration to take immediate action to address inhalation exposure to the SARS-CoV-2 virus as a cornerstone of the COVID-19 pandemic response.

Clinical Trial to Investigate whether Hypertension Drug Ameliorates COVID-19 Severity

April 30, 2020

UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

Why Subvariants of the SARS-CoV-2 Virus Accelerated the Pandemic

March 22, 2023

UC San Diego researchers describe why SARS-CoV-2 subvariants spread more rapidly than the original virus strain, and how an early treatment might have made people more susceptible to future infections.

UC San Diego Researchers Add Monkeypox to Wastewater Surveillance

August 10, 2022

A UC San Diego-led program that monitors wastewater for the presence of SARS-CoV-2 and which has effectively predicted subsequent surges in COVID-19 cases in San Diego has been expanded to detect the presence of monkeypox.

Common Medication Used to Reduce Cholesterol Levels May Reduce COVID-19 Severity 

July 15, 2021

Using anonymized medical records from a national registry, UC San Diego researchers confirm earlier findings that statins may substantially minimize adverse outcomes from SARS-CoV-2 infection.

Letter from Leading Researchers Urges Terminology Update, Shift in COVID-19 Guidance

October 5, 2020

Scientists affiliated with leading research institutions across the U.S. state in a letter published Monday in the journal Science that researchers across disciplines must converge to deliver clear public health guidance about how SARS-CoV-2 is spread in the air.

Common Diabetes Drug Shows Promise as Treatment for COVID-19 Lung Inflammation

June 8, 2021

Researchers identify molecular mechanism for the anti-inflammatory activity of diabetes drug metformin and, in mouse studies, say it prevents lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19.

UC San Diego Leads Research that Earns Gordon Bell Special Prize

November 19, 2020

Computational Chemist Rommie Amaro, members of her lab win one of the most coveted awards in supercomputing for research related to COVID-19

Asymptomatic Testing Central to UC San Diego’s Return to Learn for Fall Quarter

June 25, 2020

The University of California San Diego today announced the next step in its Return to Learn program, which will guide an incremental repopulation of the campus while offering broad, asymptomatic testing for faculty, staff and students on a recurring basis to detect the presence of SARS-CoV-2, the no

Awash in Potential: Wastewater Provides Early Detection of SARS-CoV-2 Virus

July 7, 2022

Scientists and physicians at UC San Diego and Scripps Research describe how wastewater sequencing provided dramatic new insights into levels and variants of SARS-CoV-2 on campus and in the broader community — a key step to public health interventions in advance of COVID-19 case surges.

Category navigation with Social links